Tenax Therapeutics, Inc. · NASDAQ:TENX

Raymond Debbane reported a 9.40% stake in Tenax Therapeutics, Inc. (Schedule 13G)

Event Sep 26, 2025 · Filed Oct 2, 2025

Raymond Debbane reported a 9.40% stake in Tenax Therapeutics, Inc., 427,141 shares, as a passive investor on Sep 26, 2025. Filed Oct 2, 2025 (Schedule 13G).

Stake
9.40%
Shares
427,141
Intent
Passive
What changed
Crossed above 5%
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.8.00%366,143
Invus Public Equities Advisors, LLC8.00%366,143
Invus Global Management, LLC8.00%366,143
Siren, L.L.C.8.00%366,143
Avicenna Life Sci Master Fund LP1.30%60,998
Avicenna Life Sci Master GP LLC1.30%60,998
Ulys, L.L.C.1.30%60,998
Raymond Debbane9.40%427,141

Source

View original at SEC

Related